pH-responsive hydrogels with dispersed hydrophobic nanoparticles for the delivery of hydrophobic therapeutic agents

Polymer International

Volumn 61, Issue 6, 2012, Pages 874-879

  Schoener, Cody A ^a   Hutson, Heather N ^a   Peppas, Nicholas A ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Controlled release; Drug delivery; Fluorescein; Hydrogels; Nanoparticles; PH responsive

Indexed keywords

CONTROLLED RELEASE; CROSSLINKED; EQUILIBRIUM SWELLING; FLUORESCEIN; HYDROGEL STRUCTURE; HYDROPHOBIC CONTENT; HYDROPHOBIC NANOPARTICLES; LOADING EFFICIENCY; LOW MOLECULAR WEIGHT DRUGS; METHACRYLIC ACIDS; NEUTRAL PH; PH-RESPONSIVE; PH-RESPONSIVE HYDROGELS; PMMA NANOPARTICLES; POLYMER CARRIER; RELEASE PROFILES; SMALL INTESTINE; SWELLING BEHAVIOR; SWELLING RATIO; THERAPEUTIC AGENTS; TRIGGERED RELEASE; TWO-COMPONENT;

BIOMATERIALS; DRUG DELIVERY; ESTERS; FUNCTIONAL POLYMERS; HYDROPHOBICITY; NANOPARTICLES; POLYETHYLENE GLYCOLS;

HYDROGELS;

EID: 84861225855     PISSN: 09598103     EISSN: 10970126     Source Type: Journal    
DOI: 10.1002/pi.4219     Document Type: Article

References (49)

1. Peppas NA, Bures P, Leobandung W and Ichikawa H, Eur J Pharm Biopharm 50: 27-46 (2000).
2. Peppas NA and Kim B, J Drug Deliv Sci Technol 16: 11-18 (2006).
3. Blanchette J, Kavimandan N and Peppas NA, Biomed Pharmacother 58: 142-151 (2004).
4. Irshad S and Maisey N, Eur J Cancer Care 19: 5-11 (2010).
5. Liu G, Franssen E, Fitch MI and Warner E, J Clin Oncol 15: 110-115 (1997).
6. Mao JH and Balmain A, Curr Opin Genet Dev 13: 14-19 (2003).
7. Ohmori K, Sasaki K, Asada S, Tanaka N and Umeda M, Mutat Res, Genet Toxicol Environ Mutagen 557: 191-202 (2004).
8. Schrenk D, Schmitz HJ, Bohnenberger S, Wagner B and Worner W, Toxicol Lett 149: 43-50 (2004).
9. Wolfle D, Toxicology 188: 139-147 (2003).
10. Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, et al, J Clin Oncol 19: 4097-4106 (2001).
11. Boeck S, Wilkowski R, Bruns CJ, Issels RD, Schulz C, Moosmann N, et al, Oncology 73: 221-227 (2007).
12. Beach DF and Somer R, J Clin Oncol 29: E397-E401 (2011).
13. Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, et al, Eur J Cancer 34: 1274-1281 (1998).
14. Nuño-Donlucas SM, Sánchez-Díaz JC, Rabelero M, Cortés-Ortega J, Luhrs-Olmos CC, Fernández-Escamilla VV, et al, J Colloid Interface Sci 270: 94-98 (2004).
15. Geng H, Song H, Qi J and Cui D, Nanoscale Res Lett 6: 312-319 (2011).
16. Varaprasad K, Mohan YM, Ravindra S, Reddy NN, Vimala K, Monika K, et al, J Appl Polym Sci 115: 1199-1207 (2010).
17. Zhang J and Peppas NA, Macromolecules 33: 102-107 (2000).
18. Owens III DE and Peppas NA, Int J Pharm 307: 93-102 (2006).
19. Hamidi M, Azadi A and Rafiei P, Adv Drug Delivery Rev 60: 1638-1649 (2008).
20. Caldorera-Moore M, Guimard N, Shi L and Roy K, Expert Opin Drug Delivery 7: 479-495 (2010).
21. Thomas JB, Tingsanchali JH, Rosales AM, Creecy CM, McGinity JW and Peppas NA, Polymer 48: 5042-5048 (2007).
22. Bell CL and Peppas NA, Biomaterials 17: 1203-1218 (1996).
23. Hassan CM, Doyle FJ and Peppas NA, Macromolecules 30: 6166-6173 (1997).
24. Robinson DN and Peppas NA, Macromolecules 35: 3668-3674 (2002).
25. Yamagata T, Morishita M, Kavimandan NJ, Nakamura K, Fukuoka Y, Takayama K, et al, J Controlled Release 112: 343-349 (2006).
26. Lowman AM, Morishita M, Kajita M, Nagai T and Peppas NA, J Pharm Sci 88: 933-937 (1999).
27. Nakamura K, Murray RJ, Joseph JI, Peppas NA, Morishita M and Lowman AM, J Controlled Release 95: 589-599 (2004).
28. Kavimandan NJ, Losi E and Peppas NA, Biomaterials 27: 3846-3854 (2006).
29. Carr DA, Gomez-Burgaz M, Boudes MC and Peppas NA, Ind Eng Chem Res 49: 11991-11995 (2010).
30. Torres-Lugo M and Peppas NA, Macromolecules 32: 6646-6651 (1999).
31. Morishita M, Kamei N, Chiba H, Kavimandan NJ, Peppas NA and Takayama K, J Controlled Release 134: 98-102 (2009).
32. Blanchette J and Peppas NA, Ann Biomed Eng 33: 142-149 (2005).
33. Blanchette J, Park K and Peppas NA, Trans Soc Biomater 89: 1606-1613 (2003).
34. Camli ST, Buyukserin F, Balci O and Budak GG, J Colloid Interface Sci 344: 528-532 (2010).
35. Yuan Q, Shah J, Hein S and Misra RDK, Acta Biomaterialia 6: 1140-1148 (2010).
36. Hou Y, Schoener CA, Regan KR, Munoz-Pinto D, Hahn MS and Grunlan MA, Biomacromolecules 11: 648-656 (2010).
37. Zhang J, Qian ZY and Gu YQ, Nanotechnology 20: 1-8 (2009).
38. Patel RB, Carlson AN, Solorio L and Exner AA, J Biomed Mater Res 94A: 476-484 (2010).
39. Reddy SM, Sinha VR and Reddy DS, Drugs Today 35: 537-580 (1999).
40. Buruaga L and Pomposo JA, Polymers 3: 1673-1683 (2011).
41. Gibson N, Shenderova O, Luo TJM, Moseenkov S, Bondar V, Puzyr A, et al, Diamond Relat Mater 18: 620-626 (2009).
42. Hartig SM, Greene R, Carlesso G, Higginbotham JN, Khan WN, Prokop A, et al, Biomaterials 28: 3843-3855 (2007).
43. Blanchette J and Peppas NA, J Biomed Mater Res 72A: 381-388 (2005).
44. Peppas NA, Wood KM and Blanchette JO, Expert Opin Biol Ther 4: 881-887 (2004).
45. Schoener CA, Hutson HN, Fletcher GK and Peppas NA, Ind Eng Chem Res 50: 12556-12561 (2011).
46. Wood KM, Stone GM and Peppas NA, Biomacromolecules 9: 1293-1298 (2008).
47. Phillips MR and Peppas NA, Transactions of Annual Biomaterials Meeting 33: 267 (2009).
48. Krishnaiah YSR, Satyanarayana V, Kumar BD, Karthikeyan RS and Bhaskar P, Eur J Pharm Sci 19: 355-362 (2003).
49. Liu R, Li D, He B, Xu X, Sheng M, Lai Y, et al, J Controlled Release 152: 49-56 (2011).